日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Optimal Adjuvant Therapy Selection for Chinese BRAF V600-Mutant Stage III Melanoma: A Multicenter Efficacy Comparison of Targeted Agents, Immunotherapy, and Combinatorial Strategies

中国BRAF V600突变型III期黑色素瘤最佳辅助治疗方案选择：靶向药物、免疫疗法和联合治疗策略的多中心疗效比较

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70738
Zhang, Rongcheng; Liang, Yao; Li, Jingjing; Chen, Qianqi; Ding, Ya; Wen, Xizhi; Zhao, Baiwei; Zheng, Wei; Wu, Junwan; Zhang, Qiong; Chen, Ziluan; Ding, Qiuyue; Chen, Linbin; Li, Renai; Li, Ke; Zhou, Qiming; Zhang, Xiaoshi; Li, Dandan
免疫/内分泌
黑色素瘤
BRAF
发表日期：2026
文献求助 收藏

Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal Melanoma

术后辅助放化疗联合免疫检查点抑制剂可显著延长鼻窦黏膜黑色素瘤患者的无复发生存期

期刊:Journal of Otolaryngology-Head & Neck Surgery
影响因子:2.2
doi:10.1177/19160216251414150
Ding, Qiuyue; Wu, Junwan; Ding, Ya; Li, Dandan; Wen, Xizhi; Jiang, Hang; Chen, Linbin; Zhang, Qiong; Zhang, Yuan; Lu, Lixia; Zhang, Xiaoshi; Li, Jingjing
Checkpoint
黑色素瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAF(V600)-mutant advanced melanoma: a multicenter cohort study

在BRAF抑制剂靶向治疗的基础上加用抗PD-1免疫疗法可改善BRAF(V600)突变型晚期黑色素瘤患者的真实世界生存期并延缓脑转移：一项多中心队列研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70102
Wu, Junwan; Ding, Qiuyue; Zhang, Qiong; Chen, Qianqi; Wen, Xizhi; Ding, Ya; Li, Jingjing; Chen, Ziluan; Zhang, Tao; Wang, Jiuhong; Huang, Fuxue; Jiang, Hang; Chen, Linbin; Zhou, Qiming; Li, Ke; Zhang, Xiaoshi; Li, Dandan
黑色素瘤
BRAF
神经科学
PD-1
免疫/内分泌
发表日期：2025
文献求助 收藏

Effectiveness of eHealth for Medication Adherence in Renal Transplant Recipients: Systematic Review and Meta-Analysis

电子健康对肾移植受者用药依从性的有效性：系统评价和荟萃分析

期刊:Journal of Medical Internet Research
影响因子:6
doi:10.2196/73520
Zhou, Lili; Cheng, Ke; Chen, Linbin; Hou, Xinyi; Wan, Jingjing
发表日期：2025
文献求助 收藏

Investigating the pathways of medication adherence in renal transplant recipients based on the COM-B model: the parallel mediating effects of beliefs and emotion regulation efficacy

基于COM-B模型探讨肾移植受者药物依从性的途径：信念和情绪调节效能的平行中介效应

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1702618
Zhou, Lili; Cheng, Ke; Chen, Linbin; Han, San; Wan, Jingjing
发表日期：2025
文献求助 收藏

Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma.

自然杀伤细胞激活特征表明细胞周期蛋白 B1/CDK1 可作为药物靶点，以克服黑色素瘤中自然杀伤细胞功能障碍和肿瘤侵袭性

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph18050666
Chen Linbin, Liao Wanqian, Huang Jing, Ding Qiuyue, Wu Junwan, Zhang Qiong, Ding Ya, Li Dandan, Li Jingjing, Wen Xizhi, Zhang Xiaoshi
肿瘤
黑色素瘤
发表日期：2025
文献求助 收藏

Neutrophil extracellular traps contribute to myofibroblast differentiation and scar hyperplasia through the Toll-like receptor 9/nuclear factor Kappa-B/interleukin-6 pathway

中性粒细胞胞外陷阱通过 Toll 样受体 9/核因子 κB/白细胞介素 6 通路促进肌成纤维细胞分化和瘢痕增生

期刊:Burns & Trauma
影响因子:6.3
doi:10.1093/burnst/tkac044
Yiming Shao, Zaiwen Guo, Yunxi Yang, Lu Liu, Jiamin Huang, Yi Chen, Linbin Li, Bingwei Sun
信号转导
细胞生物学
粒细胞
Toll-Like Receptor
发表日期：2022
文献求助 收藏

Single-Cell Transcriptome Profiling Reveals Neutrophil Heterogeneity and Functional Multiplicity in the Early Stage of Severe Burn Patients

单细胞转录组分析揭示严重烧伤患者早期中性粒细胞异质性和功能多样性

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2021.792122
Jiamin Huang, Zhechen Zhu, Dongdong Ji, Ran Sun, Yunxi Yang, Lu Liu, Yiming Shao, Yi Chen, Linbin Li, Binwei Sun
免疫
细胞生物学
粒细胞
发表日期：2022
文献求助 收藏

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

肿瘤特异性 T 细胞中 G 蛋白信号调节剂 1 的靶向作用可增强其向乳腺癌的运输

期刊:Nature Immunology
影响因子:27.7
doi:10.1038/s41590-021-00939-9
Di Huang #, Xueman Chen #, Xin Zeng #, Liyan Lao, Jiaqian Li, Yue Xing, Yiwen Lu, Qian Ouyang, Jianing Chen, Linbin Yang, Fengxi Su, Herui Yao, Qiang Liu, Shicheng Su, Erwei Song
信号转导
肿瘤
乳腺癌
T细胞
T Cell Receptor
发表日期：2021
文献求助 收藏

The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer

IRENA lncRNA 将化疗极化的肿瘤抑制巨噬细胞转化为乳腺癌中的肿瘤促进表型

期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-021-00196-7
Jiang Liu #, Liyan Lao #, Jianing Chen #, Jiang Li, Wenfeng Zeng, Xiaofeng Zhu, Jiaqian Li, Xueman Chen, Linbin Yang, Yue Xing, Fei Chen, Di Huang, Xiaoqian Zhang, Wei Wei, Chang Gong, Shuya Huang, Zhigang Yu, Zhihua Li, Linhan Yang, Jinping Liu, Xiaozhen Liu, Qinghui Zheng, Xuli Meng, Jing Liang, L
肿瘤
乳腺癌
巨噬细胞
发表日期：2021
文献求助 收藏